Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumors 1Solid Tumor, Adult 1

Interventions

pembrolizumab 305Paclitaxel 205Carboplatin 201Gemcitabine 173Cisplatin 140Docetaxel 138Cyclophosphamide 137Nivolumab 129Bevacizumab 118Injections 112fludarabine 97atezolizumab 91Pemetrexed 91Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Midazolam 55Lenalidomide 55Ipilimumab 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × PankoMab-GEX × Clear all
NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed
50 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT01222624 2021-05-20

PankoMab-GEXâ„¢: Phase 1 Dose Escalation Study

Glycotope GmbH

Phase 1 Completed
74 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡